FORM 3 |
UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 INITIAL STATEMENT OF BENEFICIAL OWNERSHIP OF SECURITIES Filed pursuant to Section 16(a) of the Securities Exchange Act of 1934 or Section 30(h) of the Investment Company Act of 1940 |
|
1. Name and Address of Reporting Person*
(Street)
|
2. Date of Event Requiring Statement
(Month/Day/Year) 01/01/2013 |
3. Issuer Name and Ticker or Trading Symbol
ISIS PHARMACEUTICALS INC [ ISIS ] |
|||||||||||||
4. Relationship of Reporting Person(s) to Issuer
(Check all applicable)
|
5. If Amendment, Date of Original Filed
(Month/Day/Year) |
||||||||||||||
6. Individual or Joint/Group Filing (Check Applicable Line)
|
Table I - Non-Derivative Securities Beneficially Owned | |||
---|---|---|---|
1. Title of Security (Instr. 4) | 2. Amount of Securities Beneficially Owned (Instr. 4) | 3. Ownership Form: Direct (D) or Indirect (I) (Instr. 5) | 4. Nature of Indirect Beneficial Ownership (Instr. 5) |
Common Stock | 2,328 | D |
Table II - Derivative Securities Beneficially Owned (e.g., puts, calls, warrants, options, convertible securities) | |||||||
---|---|---|---|---|---|---|---|
1. Title of Derivative Security (Instr. 4) | 2. Date Exercisable and Expiration Date (Month/Day/Year) | 3. Title and Amount of Securities Underlying Derivative Security (Instr. 4) | 4. Conversion or Exercise Price of Derivative Security | 5. Ownership Form: Direct (D) or Indirect (I) (Instr. 5) | 6. Nature of Indirect Beneficial Ownership (Instr. 5) | ||
Date Exercisable | Expiration Date | Title | Amount or Number of Shares | ||||
Employee Stock Option (right to buy) | 01/02/2011 | 01/01/2014 | Common Stock | 1,350 | $11.12 | D | |
Employee Stock Option (right to buy) | 01/02/2012 | 01/01/2015 | Common Stock | 14,000 | $15.38 | D | |
Employee Stock Option (right to buy) | 01/01/2013 | 12/31/2015 | Common Stock | 25,000 | $14.18 | D | |
Employee Stock Option (right to buy) | (1) | 01/01/2016 | Common Stock | 9,400 | $14.47 | D | |
Employee Stock Option (right to buy) | (2) | 01/03/2017 | Common Stock | 17,400 | $11.27 | D | |
Employee Stock Option (right to buy) | (3) | 08/31/2017 | Common Stock | 6,700 | $8 | D | |
Employee Stock Option (right to buy) | (4) | 01/02/2018 | Common Stock | 19,000 | $10.29 | D | |
Employee Stock Option (right to buy) | (5) | 01/02/2019 | Common Stock | 19,500 | $7.25 | D | |
Restricted Stock Unit | (6) | (6) | Common Stock | 2,166 | (7) | D |
Explanation of Responses: |
1. Grant of 1/2/09 to reporting person of stock options under the Isis Pharmaceuticals, Inc. 1989 Stock Option Plan. 25% of the shares subject to the option vested and became exercisable on 1/2/10. Thereafter, the remaining shares subject to the option vested and became exerciable in 36 equal monthly installments, at the rate of 2,350 shares per year. The option is exercisable as to 9,204 on 1/1/13. |
2. Grant of 1/4/10 to reporting person of stock options under the Isis Pharmaceuticals, Inc. 1989 Stock Option Plan. 25% of the shares subject to the option vested and became exercisable on 1/4/11. Thereafter, the remaining shares subject to the option vested and became exerciable in 36 equal monthly installments, at the rate of 4,350 shares per year. The option is exercisable as to 12,687 on 1/1/13. |
3. Grant of 9/1/10 to reporting person of stock options under the Isis Pharmaceuticals, Inc. 1989 Stock Option Plan. 25% of the shares subject to the option vested and became exercisable on 9/1/11. Thereafter, the remaining shares subject to the option vested and became exerciable in 36 equal monthly installments, at the rate of 2,500 shares per year. The option is exercisable as to 2,533 on 1/1/13. SAY SOMETHING ABOUT OPTIONS ALREADY EXERCISED???? |
4. Grant of 1/3/11 to reporting person of stock options under the Isis Pharmaceuticals, Inc. 1989 Stock Option Plan. 25% of the shares subject to the option vested and became exercisable on 1/3/12. Thereafter, the remaining shares subject to the option vested and became exerciable in 36 equal monthly installments, at the rate of 5,750 shares per year. The option is exercisable as to 7,020 on 1/1/13. SAY SOMETHING ABOUT OPTIONS ALREADY EXERCISED???? |
5. Grant of 1/3/12 to reporting person of stock options under the Isis Pharmaceuticals, Inc. 1989 Stock Option Plan. 25% of the shares subject to the option vested and became exercisable on 1/3/13. Thereafter, the remaining shares subject to the option vested and became exerciable in 36 equal monthly installments, at the rate of 4,875 shares per year. The option is exercisable as to 0 on 1/1/13. |
6. The restricted stock units vest in four equal annual installments, the first installment vesting on January 15, 2013. Upon vesting, the restricted stock units will be paid out in whole shares of Isis common stock or cash as may be determined by the Company. The RSU shall be fully vested on January 15, 2016. The RSU is vested as to 0 shares on January 1, 2012. |
7. Each restricted stock unit represents a contingent right to receive one share of Isis common stock or its equivalent cash value. |
Remarks: |
/s/Patrick O'Neil | 01/03/2013 | |
** Signature of Reporting Person | Date | |
Reminder: Report on a separate line for each class of securities beneficially owned directly or indirectly. | ||
* If the form is filed by more than one reporting person, see Instruction 5 (b)(v). | ||
** Intentional misstatements or omissions of facts constitute Federal Criminal Violations See 18 U.S.C. 1001 and 15 U.S.C. 78ff(a). | ||
Note: File three copies of this Form, one of which must be manually signed. If space is insufficient, see Instruction 6 for procedure. | ||
Persons who respond to the collection of information contained in this form are not required to respond unless the form displays a currently valid OMB Number. |